Document is current
Any future updates will be listed below
-
Authors
Chen, Xinyan
Raiff, Anat
Li, Shanshan https://orcid.org/0000-0002-7041-5960
Guo, Qiong
Zhang, Jiahai
Zhou, Hualin
Timms, Richard T. https://orcid.org/0000-0001-7275-597X
Yao, Xuebiao https://orcid.org/0000-0001-8982-5911
Elledge, Stephen J. https://orcid.org/0000-0001-7923-6283
Koren, Itay https://orcid.org/0000-0002-5693-1651
Zhang, Kaiming https://orcid.org/0000-0003-0414-4776
- License Information
-
More Information
Article History
Received: 13 October 2023
Accepted: 16 April 2024
First Online: 26 April 2024
Change Date: 1 July 2024
Change Type: Update
Change Details: The Reporting Summary was missing from this article and has now been uploaded. The original article has been corrected.
Competing interests
: S.J.E. is a founder of MAZE Therapeutics, Mirimus, TSCAN Therapeutics and ImmuneID, and serves on the scientific advisory board of Homology Medicines, TSCAN Therapeutics and MAZE Therapeutics; none of these associations impacts this work. All other authors declare no competing interests.
